Identity
- Security key
- 11240
- Ticker
- ACHV
- Type
- CS — Common Stock
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 1995-10-12
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- ACHV
Detail
Enriched 2026-08-14 20:47
- Market cap
- $686,789,091.33
- Shares outstanding (class)
- 102,659,057
- Shares outstanding (weighted)
- 102,659,057
- SIC
- 2835 IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
- Employees
- 28
- Location
- SEATTLE, WA
- Description
Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.